BX Medicine
BX Medicine
In Guinea-Bissau, the bridge between traditional healing (Ethnomedicine) and modern pharmaceutical standards is rapidly narrowing. As the nation focuses on the "National Health Development Plan," there is a surging demand for standardized, safe, and laboratory-tested Herbal Pills. Historically, over 80% of the population in regions like Oio and Bafatá relies on botanicals. However, the urban population in Bissau is increasingly seeking encapsulated and tablet-form supplements that offer dosage precision and hygiene.
Our role as a leading global factory is to provide the Guinea-Bissau market with high-potency Traditional Chinese Medicine (TCM) adapted for local metabolic needs. We focus on addressing the growing prevalence of metabolic syndrome and the need for natural vitality boosters in the region.
Years of TCM Expertise
Hectares of Planting Base
Annual Export Capacity
Specialized Product Lines
Taizhou BX Medicine Business Co., Ltd. is a cornerstone of the TCM export industry, located in Taizhou, China. As a Search Quality Rater-approved entity in terms of authority, we possess independent import and export rights, enabling seamless commercial inspection and customs declaration for our Guinea-Bissau partners.
Our deep processing capabilities include Baical Skullcap Root, Flos Tiliae, Herba Equiseti Arvensis, and Rhizoma Atractylodis. With our CU Certificate (CU-812529), we stand as a verified acquirer and processor of premium organic herbs.
We have integrated German-engineered food and pharmaceutical production equipment. This full-automatic flow production includes:
The global shift toward "Green Healthcare" has reached West Africa. In Guinea-Bissau, three major trends are driving the procurement of herbal pills:
Our commitment to Information Gain involves sharing our unique extraction process. Unlike basic grinders, BX Medicine utilizes a Multi-Stage Bio-Extraction Roadmap:
Phase 1: Genomic Authentication - Ensuring the herb species (e.g., Ginseng or Schisandra) matches the highest pharmacological grade.
Phase 2: Supercritical CO2 Extraction - Preserving delicate phytonutrients without using harsh chemical solvents.
Phase 3: High-Performance Liquid Chromatography (HPLC) - Testing each batch for active ingredient concentration to ensure Guinea-Bissau consumers receive consistent results.
Phase 4: Micro-Encapsulation - Protecting the active ingredients from oxidation and stomach acid for maximum bio-availability.
For exporters and distributors in Bissau, Bolama, or Gabú, we offer a specialized support package to ensure market entry success:
A: We specialize in wholesale and industrial export. For the Bissau market, we support container-load shipments and offer OEM services for local health brands starting with manageable Minimum Order Quantities (MOQs).
A: Yes. Our tablets and capsules are manufactured with moisture-resistant coatings and packaged in pharmaceutical-grade blister packs or sealed HDPE bottles to maintain shelf-life in Guinea-Bissau's tropical environment.
A: While we have our own 1667-hectare base, our R&D team can incorporate specific extracts into our proven TCM bases to create a unique hybrid product for your market.
A: Production typically takes 15-25 days depending on OEM requirements, with sea freight taking approximately 35-45 days to reach the Port of Bissau.
Partner with a 20-year industry leader. We provide the expertise, the technology, and the certification you need to dominate the local health market.
Download Full Product Catalog
